Nxera Pharma Co Eulerpool Nieuws

Nxera Pharma Co Eulerpool News

Nxera Pharma Co Aandeel Nieuws

Nxera Pharma Co wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Nxera Pharma Co nieuwsberichten verzamelen we hier.

• 9 juli ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• 9 juli ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• 27 juni ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• 18 juni ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• 30 mei ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
• 30 mei ·

  Yahoo
  Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
• 9 mei ·

  Yahoo
  Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
• 9 mei ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024
• 17 april ·

  Yahoo
  Nxera Pharma: Notice of Issuance of New Shares Under the Restricted Stock Unit (RSU) Plan and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU Plan
• 16 april ·

  Yahoo
  Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568